The World Health Organization (WHO) called on Wednesday for an immediate ban on the use of blood tests to detect active tuberculosis, saying they produced wrong results and left millions of lives at risk.
And in unusually frank terms, the U.N. agency suggested that mainly Western test-kit manufacturers misled their customers in developing countries with unfounded claims about their worth and used "perverse financial incentives" to boost sales.
A year-long rigorous analysis by its own and independent health experts uncovered "overwhelming evidence....that the blood tests produced an unacceptable level of wrong results," a statement from the WHO said.
In at least 50 percent of cases, the tests -- only used in developing countries and mainly in the private sector -- found sick people to be TB-free and healthy people to have the disease, the agency's Mario Raviglione told a news conference.
"This means that tens of thousands of people with TB get no treatment, so they are highly likely to infect many, many others," he said. "And a similar number of healthy people are given useless treatment."
The tests, which have no regulatory approval anywhere and are not used in richer nations, "must be stopped immediately and everywhere," Raviglione said.
It is the first time the WHO has issued an explicit "negative" policy recommendation against a practice used in the care of TB -- which kills 1.7 million people a year.
At least two million of the tests are carried out each year in some 17 poorer countries -- including China and India -- almost exclusively in the private or semi-private sector, according to the WHO.
WHO TB specialist Karin Weyer told the news conference that the WHO had been asked by the government of India to launch a detailed analysis of the tests -- on sale since the mid-1990s.
They were often "targeted at countries with weak regulatory mechanisms for diagnostics, where questionable marketing incentives can override the interests of patients," Weyer said.
"It is a multi-million dollar business centered on selling sub-standard tests with unreliable results."
A separate WHO policy statement said most of the tests "have no published evidence to support their claims of accuracy.
And it declared that there were "perverse financial incentives that may encourage the blood tests to be used by doctors, laboratories, diagnostic companies and other stakeholders" in those countries.
A report from the expert group that carried out the analysis on the WHO TB website (www.who.int/tb) shows that most of the 18 known manufacturers are based in advanced economies, although the test kits are also made in China, India and Singapore.
Most -- including those based in the United States, Britain, France, Germany, Italy, Japan and the Netherlands -- are small, privately-owned companies in the medical diagnostic sector, the WHO report indicated.
One listed company, Omega Diagnostics based in Scotland, said the test-kits accounted for less than 2 per cent of its revenues and it would wait for feedback on the WHO statement from its customers before deciding how to proceed.
"We will take it on a case by case basis. I think just a mass withdrawal probably wouldn't be the way to go but we will respond to our customers' particular market requirements," Omega group sales and marketing director Jag Grewal told Reuters.
Grewal said there was "a fair degree of acceptance of this test," adding that "it is being used today in the context that no test is perfect."
Copyright 2011 Thomson Reuters. Click for Restrictions.
Our 2024 Coverage Needs You
It's Another Trump-Biden Showdown — And We Need Your Help
The Future Of Democracy Is At Stake
Our 2024 Coverage Needs You
Your Loyalty Means The World To Us
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
The 2024 election is heating up, and women's rights, health care, voting rights, and the very future of democracy are all at stake. Donald Trump will face Joe Biden in the most consequential vote of our time. And HuffPost will be there, covering every twist and turn. America's future hangs in the balance. Would you consider contributing to support our journalism and keep it free for all during this critical season?
HuffPost believes news should be accessible to everyone, regardless of their ability to pay for it. We rely on readers like you to help fund our work. Any contribution you can make — even as little as $2 — goes directly toward supporting the impactful journalism that we will continue to produce this year. Thank you for being part of our story.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
It's official: Donald Trump will face Joe Biden this fall in the presidential election. As we face the most consequential presidential election of our time, HuffPost is committed to bringing you up-to-date, accurate news about the 2024 race. While other outlets have retreated behind paywalls, you can trust our news will stay free.
But we can't do it without your help. Reader funding is one of the key ways we support our newsroom. Would you consider making a donation to help fund our news during this critical time? Your contributions are vital to supporting a free press.
Contribute as little as $2 to keep our journalism free and accessible to all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. Would you consider becoming a regular HuffPost contributor?
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. If circumstances have changed since you last contributed, we hope you'll consider contributing to HuffPost once more.
Support HuffPostAlready contributed? Log in to hide these messages.